AEterna Zentaris Total Assets 2006-2020 | AEZS

AEterna Zentaris total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
AEterna Zentaris Annual Total Assets
(Millions of US $)
2019 $20
2018 $25
2017 $22
2016 $32
2015 $51
2014 $47
2013 $59
2012 $68
2011 $75
2010 $77
2009 $86
2008 $108
2007 $123
2006 $223
2005 $426
AEterna Zentaris Quarterly Total Assets
(Millions of US $)
2020-06-30 $18
2020-03-31 $20
2019-12-31 $20
2019-09-30 $22
2019-06-30 $21
2019-03-31 $22
2018-06-30 $32
2018-03-31 $36
2017-12-31 $22
2017-09-30 $23
2017-06-30 $25
2017-03-31 $28
2016-12-31 $32
2016-09-30 $32
2016-06-30 $37
2016-03-31 $44
2015-12-31 $51
2015-09-30 $49
2015-06-30 $57
2015-03-31 $65
2014-12-31 $47
2014-09-30 $56
2014-06-30 $54
2014-03-31 $62
2013-12-31 $59
2013-09-30 $50
2013-06-30 $53
2013-03-31 $59
2012-12-31 $68
2012-09-30 $58
2012-06-30 $65
2012-03-31 $74
2011-12-31 $75
2011-09-30 $75
2011-06-30 $79
2011-03-31 $69
2010-12-31 $77
2010-09-30 $81
2010-06-30 $86
2010-03-31 $72
2009-12-31 $86
2009-09-30 $104
2009-06-30 $117
2009-03-31 $119
2008-12-31 $108
2008-09-30 $73
2008-06-30 $96
2008-03-31 $118
2007-12-31 $123
2007-09-30 $134
2007-06-30 $135
2007-03-31 $139
2006-12-31 $223
2006-09-30 $432
2006-06-30 $436
2006-03-31 $424
2005-12-31 $426
2005-09-30 $299
2005-06-30 $305
2005-03-31 $388
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.019B $0.001B
AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead oncology program is a Phase 2 trial in endometrial and ovarian cancer with AEZS-108, a targeted cytotoxic peptide conjugate. Other lead compounds include ozarelix for BPH and prostate cancer as well as perifosine for multiple cancers.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.504B 10.59
Amgen (AMGN) United States $135.125B 14.68
CSL (CSLLY) Australia $97.635B 0.00
Gilead Sciences (GILD) United States $75.938B 10.93
Regeneron Pharmaceuticals (REGN) United States $62.042B 23.72
Vertex Pharmaceuticals (VRTX) United States $57.436B 32.05
Illumina (ILMN) United States $46.904B 54.54
Biogen (BIIB) United States $42.550B 7.28
Seattle Genetics (SGEN) United States $34.490B 0.00
Moderna (MRNA) United States $28.000B 0.00
BeiGene (BGNE) Cayman Islands $27.327B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.687B 11.12
Genmab (GMAB) Denmark $23.717B 14.96
Genmab (GNMSF) Denmark $22.414B 5.16
BioNTech SE (BNTX) Germany $21.251B 0.00
Immunomedics (IMMU) United States $20.250B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.204B 0.00
Incyte (INCY) United States $19.193B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.310B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.199B 37.90
Exact Sciences (EXAS) United States $16.089B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
BioMarin Pharmaceutical (BMRN) United States $14.024B 101.75
ARGENX SE-ADR (ARGX) Netherlands $12.418B 0.00
QIAGEN (QGEN) Netherlands $11.909B 30.23
MyoKardia (MYOK) United States $11.764B 0.00
Sarepta Therapeutics (SRPT) United States $11.053B 0.00
Guardant Health (GH) United States $10.215B 0.00
Bio-Techne Corp (TECH) United States $10.201B 70.00
Repligen (RGEN) United States $8.860B 140.63
Mirati Therapeutics (MRTX) United States $8.681B 0.00
Galapagos (GLPG) Belgium $8.520B 30.83
Ascendis Pharma (ASND) Denmark $8.274B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.559B 234.17
Exelixis (EXEL) United States $6.974B 25.36
Acceleron Pharma (XLRN) United States $6.901B 0.00
Adaptive Biotechnologies (ADPT) United States $6.749B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.542B 0.00
Novavax (NVAX) United States $6.253B 0.00
Blueprint Medicines (BPMC) United States $5.742B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.730B 15.66
Ultragenyx Pharmaceutical (RARE) United States $5.523B 0.00
Emergent Biosolutions (EBS) United States $5.079B 20.12
NeoGenomics (NEO) United States $4.745B 1432.33
Vir Biotechnology (VIR) United States $4.649B 0.00
Denali Therapeutics (DNLI) United States $4.511B 0.00
Arena Pharmaceuticals (ARNA) United States $4.470B 0.00
China Biologic Products (CBPO) China $4.447B 26.40
Amicus Therapeutics (FOLD) United States $4.361B 0.00
Twist Bioscience (TWST) United States $4.154B 0.00
Fate Therapeutics (FATE) United States $4.127B 0.00
Halozyme Therapeutics (HALO) United States $4.037B 0.00
Reata Pharmaceuticals (RETA) United States $3.800B 0.00
Insmed (INSM) United States $3.785B 0.00
Global Blood Therapeutics (GBT) United States $3.755B 0.00
MorphoSys AG (MOR) Germany $3.626B 47.52
Bluebird Bio (BLUE) United States $3.612B 0.00
Legend Biotech (LEGN) United States $3.477B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.318B 0.00
Eidos Therapeutics (EIDX) United States $2.844B 0.00
Alkermes (ALKS) Ireland $2.691B 56.40
PHARMA MAR SA (PHMMF) Spain $2.604B 0.00
Seres Therapeutics (MCRB) United States $2.486B 0.00
Sorrento Therapeutics (SRNE) United States $2.327B 0.00
I-Mab (IMAB) China $2.322B 0.00
Editas Medicine (EDIT) United States $2.084B 0.00
Zymeworks (ZYME) Canada $2.069B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.995B 0.00
Amarin (AMRN) Ireland $1.967B 0.00
Inovio Pharmaceuticals (INO) United States $1.901B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Intra-Cellular Therapies (ITCI) United States $1.753B 0.00
Revance Therapeutics (RVNC) United States $1.697B 0.00
UniQure (QURE) Netherlands $1.669B 0.00
Beam Therapeutics (BEAM) United States $1.649B 0.00
Viela Bio (VIE) United States $1.646B 0.00
Zealand Pharma (ZEAL) Denmark $1.606B 0.00
Northwest Biotherapeutics (NWBO) United States $1.602B 0.00
Sangamo Therapeutics (SGMO) United States $1.538B 0.00
Intellia Therapeutics (NTLA) United States $1.514B 0.00
Ligand Pharmaceuticals (LGND) United States $1.495B 50.53
Dicerna Pharmaceuticals (DRNA) United States $1.493B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Epizyme (EPZM) United States $1.389B 0.00
Mesoblast (MESO) Australia $1.320B 0.00
Alcobra (ARCT) United States $1.314B 0.00
Arcus Biosciences (RCUS) United States $1.255B 0.00
Coherus BioSciences (CHRS) United States $1.220B 7.11
Cytokineticsorporated (CYTK) United States $1.168B 0.00
Mersana Therapeutics (MRSN) United States $1.152B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.127B 0.00
NGM Biopharmaceuticals (NGM) United States $1.121B 0.00
Retrophin (RTRX) United States $1.089B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.065B 0.00
Compugen (CGEN) Israel $1.043B 0.00
REGENXBIO (RGNX) United States $1.024B 0.00
Genetron Holdings (GTH) China $1.001B 0.00
Heska (HSKA) United States $0.980B 0.00
Myriad Genetics (MYGN) United States $0.978B 0.00
Castle Biosciences (CSTL) United States $0.978B 0.00
Athenex (ATNX) United States $0.967B 0.00
NantKwest (NK) United States $0.934B 0.00
Adverum Biotechnologies (ADVM) United States $0.932B 0.00
Vericel (VCEL) United States $0.929B 0.00
Arvinas (ARVN) United States $0.872B 0.00
Pliant Therapeutics (PLRX) United States $0.860B 0.00
Codexis (CDXS) United States $0.843B 0.00
Morphic Holding (MORF) United States $0.819B 0.00
Intrexon (PGEN) United States $0.809B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.804B 0.00
Cellectis S.A (CLLS) France $0.789B 0.00
Agenus (AGEN) United States $0.770B 0.00
Alector (ALEC) United States $0.768B 0.00
Protagonist Therapeutics (PTGX) United States $0.738B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.729B 0.00
MiMedx (MDXG) United States $0.727B 0.00
Frequency Therapeutics (FREQ) United States $0.714B 0.00
AnaptysBio (ANAB) United States $0.701B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Kadmon Holdings (KDMN) United States $0.667B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.666B 0.00
Cara Therapeutics (CARA) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
VBI Vaccines (VBIV) United States $0.638B 0.00
Celldex Therapeutics (CLDX) United States $0.634B 0.00
Geron (GERN) United States $0.584B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Cel-Sci (CVM) United States $0.579B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.572B 5.01
ZIOPHARM Oncology Inc (ZIOP) United States $0.544B 0.00
Anika Therapeutics (ANIK) United States $0.537B 23.49
Autolus Therapeutics (AUTL) United Kingdom $0.534B 0.00
IVERIC Bio (ISEE) United States $0.530B 0.00
Albireo Pharma (ALBO) United States $0.514B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.514B 0.00
Clovis Oncology (CLVS) United States $0.505B 0.00
MeiraGTx Holdings (MGTX) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.480B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
Dynavax Technologies (DVAX) United States $0.467B 0.00
MannKind (MNKD) United States $0.458B 0.00
Kala Pharmaceuticals (KALA) United States $0.456B 0.00
Avid Bioservices (CDMO) United States $0.455B 0.00
Cue Biopharma (CUE) United States $0.452B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.450B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Amryt Pharma (AMYT) United Kingdom $0.438B 0.00
Scholar Rock Holding (SRRK) United States $0.434B 0.00
Starpharma Holdings (SPHRY) Australia $0.429B 0.00
Sutro Biopharma (STRO) United States $0.428B 0.00
Forte Biosciences (FBRX) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.387B 0.00
Syros Pharmaceuticals (SYRS) United States $0.386B 0.00
Trevena (TRVN) United States $0.384B 0.00
Merus (MRUS) Netherlands $0.380B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.379B 0.00
Kamada (KMDA) Israel $0.374B 17.89
Aeglea BioTherapeutics (AGLE) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.357B 8.43
IBio (IBIO) United States $0.357B 0.00
BioDelivery Sciences (BDSI) United States $0.355B 25.14
Athersys (ATHX) United States $0.353B 0.00
Precision BioSciences (DTIL) United States $0.344B 0.00
AC Immune SA (ACIU) Switzerland $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.336B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.335B 0.00
Innate Pharma S.A (IPHA) France $0.324B 0.00
Cardiff Oncology (CRDF) United States $0.321B 0.00
NextCure (NXTC) United States $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.309B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.307B 0.00
WAVE Life Sciences (WVE) Singapore $0.307B 0.00
ChromaDex (CDXC) United States $0.305B 0.00
Pluristem Therapeutics (PSTI) Israel $0.285B 0.00
Affimed (AFMD) Germany $0.264B 0.00
PDL BioPharma (PDLI) United States $0.251B 0.00
Selecta Biosciences (SELB) United States $0.244B 0.00
Arbutus Biopharma (ABUS) United States $0.243B 0.00
Fortress Biotech (FBIO) United States $0.231B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.230B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
Verastem (VSTM) United States $0.217B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.202B 0.00
Eton Pharmaceuticals (ETON) United States $0.201B 0.00
Dyadic (DYAI) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.181B 0.00
DBV Technologies S.A (DBVT) France $0.177B 0.00
Theratechnologies (THTX) Canada $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
Aptinyx (APTX) United States $0.172B 0.00
GENFIT S.A (GNFT) France $0.170B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.170B 0.00
VolitionRX (VNRX) United States $0.169B 0.00
Biofrontera AG (BFRA) Germany $0.168B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Prometic Life Sciences (LMNL) Canada $0.163B 0.00
Exicure (XCUR) United States $0.162B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.152B 7.10
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
AquaBounty Technologies (AQB) United States $0.141B 0.00
Bellus Health (BLU) Canada $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.136B 0.00
SESEN BIO, INC (SESN) United States $0.131B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.131B 0.00
Liquidia Technologies (LQDA) United States $0.129B 0.00
Aytu Bioscience (AYTU) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Windtree Therapeutics (WINT) United States $0.119B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Unum Therapeutics (COGT) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.58
PhaseBio Pharaceuticals (PHAS) United States $0.107B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
Enzo Biochem (ENZ) United States $0.101B 0.00
Palatin Technologies (PTN) United States $0.099B 0.00
Cyclerion Therapeutics (CYCN) United States $0.093B 0.00
Evogene (EVGN) Israel $0.092B 0.00
Ecology Coatings (ABVC) United States $0.088B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.085B 0.00
Bionano Genomics (BNGO) United States $0.078B 0.00
Idera Pharmaceuticals (IDRA) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 71.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.066B 0.00
AmpliPhi Biosciences (ARMP) United States $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
Organovo Holdings (ONVO) United States $0.059B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.046B 0.00
Novogen (KZIA) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Vaccinex (VCNX) United States $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Celsion (CLSN) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00